3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase NA
4
Phase 3
4
Phase 1/2
2
Phase EARLY_PHASE1
1
Phase 4
1
Phase 2/3
1
Phase 1
1
Status
Completed
2
Unknown
1
Recruiting
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Peripheral Nervous System Diseases
1
Neoplasms
1
Multiple Myeloma
1
Interventions
Propofol
9
Sevoflurane
7
Rituximab
7
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Trastuzumab
5
Enoxaparin
5
Bevacizumab
5
Nivolumab
4
Carboplatin
4
Capecitabine
4
Bupivacaine
4
trametinib
3
pirtobrutinib
3
pembrolizumab
3
dabrafenib
3
atezolizumab
3
apixaban
3
Lenalidomide
3
Indocyanine Green
3
Gemcitabine
3
Docetaxel
3
Cyclophosphamide
3
zanubrutinib
2
venetoclax
2
trastuzumab deruxtecan
2
ribociclib
2
polyethylene glycol 3350
2
pertuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Recruiting
×
Tablets
×
Clear all
NCT07025005
2025-11-04
VRd MM Fibrate
Tanta University
Phase 4
Recruiting
44 enrolled